These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 3222164)
21. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684 [TBL] [Abstract][Full Text] [Related]
22. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis. Stone HH; Mullins RJ; Strom PR; Bourneuf AA; Geheber CE Am J Surg; 1984 Oct; 148(4A):30-4. PubMed ID: 6091478 [TBL] [Abstract][Full Text] [Related]
23. Imipenem/cilastatin treatment of bacterial meningitis in children. Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603 [TBL] [Abstract][Full Text] [Related]
24. Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever. Au E; Tow A; Allen DM; Ang PT Ann Acad Med Singap; 1994 Nov; 23(6):819-22. PubMed ID: 7741492 [TBL] [Abstract][Full Text] [Related]
25. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group. Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683 [TBL] [Abstract][Full Text] [Related]
26. Imipenem/cilastatin-associated hiccups. Lucena M; Andrade R; Cabello M; Clavijo E; Queipo de Llano E Ann Pharmacother; 1992 Nov; 26(11):1459. PubMed ID: 1477457 [No Abstract] [Full Text] [Related]
27. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Cox CE; Holloway WJ; Geckler RW Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765 [TBL] [Abstract][Full Text] [Related]
28. Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin. Leaper DJ; Kennedy RH; Sutton A; Johnson E; Roberts N Scand J Infect Dis Suppl; 1987; 52():7-10. PubMed ID: 3331045 [TBL] [Abstract][Full Text] [Related]
29. Imipenem/cilastatin (Primaxin): evaluation in general surgical practice. Chin MJ; Bagshaw PF; Bremner JM N Z Med J; 1991 Jan; 104(904):22-3. PubMed ID: 2008258 [No Abstract] [Full Text] [Related]
30. Use of imipenem-cilastatin in pediatrics. Overturf GD Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788 [No Abstract] [Full Text] [Related]
31. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group. Norrby SR; Finch RG; Glauser M J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130 [TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections. D'Amato C; Armignacco O; Antonucci G; Bordi E; Bove G; De Carli G; De Mori P; Rosci MA; Visco G J Chemother; 1990 Apr; 2(2):100-7. PubMed ID: 2193998 [TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ; Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073 [TBL] [Abstract][Full Text] [Related]
34. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044 [TBL] [Abstract][Full Text] [Related]
35. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections. Garau J; Blanquer J; Cobo L; Corcia S; Daguerre M; de Latorre FJ; León C; Del Nogal F; Net A; Rello J Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899 [TBL] [Abstract][Full Text] [Related]
36. Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience. Garau J; Calandra GB Chemotherapy; 1991; 37 Suppl 2():44-52. PubMed ID: 1879187 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial management of postoperative infections in abdominal surgery: single or combination regimen? Geroulanos S; Stern A; Christen D; Buchmann P Clin Ther; 1990; 12 Suppl B():34-42. PubMed ID: 2196121 [TBL] [Abstract][Full Text] [Related]
38. Imipenem-cilastatin sodium. Roach AC Crit Care Nurse; 1989 Mar; 9(3):14-8. PubMed ID: 2582800 [No Abstract] [Full Text] [Related]
39. Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Saltoglu N; Dalkiran A; Tetiker T; Bayram H; Tasova Y; Dalay C; Sert M Clin Microbiol Infect; 2010 Aug; 16(8):1252-7. PubMed ID: 19832720 [TBL] [Abstract][Full Text] [Related]
40. Treatment of intra-abdominal infections using imipenem/cilastatin. Leaper D; Thomas W; Kennedy R; Leow C; Avery D Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]